Afluria Quadrivalent is an inactivated influenza vaccine intended to protect patients against four different flu viruses — two Type A viruses and two Type B viruses. The vaccine comes in a single-dose pre-filled syringe.
In May, Seqirus received FDA approval for another quadrivalent flu vaccine called Flucelvax.
Afluria Quadrivalent will be available in the U.S. for this year’s flu season.
More articles on supply chain:
FDA fast tracks experimental drug to treat Parkinson’s
The rise of the unbranded drug ad: 5 things to know
Mylan to introduce generic EpiPen at half the price
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
